Real-time enrollment status for this t-cell acute lymphoblastic leukemia/lymphoma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 10:20 PM UTC
| NCT Number | NCT06934382 |
| Recruiting Status | Recruiting |
| Condition | T-Cell Acute Lymphoblastic Leukemia/Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 33 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stephan Grupp MD PhD |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 16, 2026: Clinical trial NCT06934382 is currently recruiting participants. This phase1 study for t-cell acute lymphoblastic leukemia/lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Stephan Grupp MD PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06934382 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06934382 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.